Health
Sanofi to start human trials of its second Covid vaccine candidate | – Macau Business
International, MNA | French pharmaceutical firm Sanofi on Friday announced the launch of human trials of its second Covid-19 vaccine, with its first still in the…
French pharmaceutical firm Sanofi on Friday announced the launch of human trials of its second Covid-19 vaccine, with its first still in the testing phase after having fallen behind in development.
Sanofi and US company Translate Bio are developing the vaccine based on messenger RNA technology.
The phase 1 and 2 trials aim to verify that the vaccine is not dangerous and to provide initial information on its effectiveness.
Phase 3 would be carried out on many more patients to determine its effectiveness.
…
-
Noosa News16 hours agoHockey coach in Arana Hills charged with grooming and sexual offences against teenage girls
-
General16 hours agoWoman killed and man injured in shark attack on NSW Mid North Coast
-
Noosa News16 hours agoDepartment of Transport and Main Roads orders shutdown of North Ipswich Free Shop
-
Noosa News19 hours agoFlawed government agreement opened door for unlawful site access